News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma to Present at the UBS Global Life Sciences Conference

BOULDER, Colo.--(BUSINESS WIRE)--Sep. 15, 2009-- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the UBS Global Life Sciences Conference on September 21 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Event:

  UBS Global Life Sciences Conference

Presenter:

Robert E. Conway, Chief Executive Officer, Array BioPharma

Date:

Monday, September 21, 2009

Time:

9:30 a.m. Eastern Time

Location:

Grand Hyatt New York

Webcast:

www.arraybiopharma.com

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory and metabolic diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.

Source: Array BioPharma Inc.

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com